Breaking News Instant updates and real-time market news.

EYEN

Eyenovia

$5.10

-0.92 (-15.28%)

08:37
02/13/19
02/13
08:37
02/13/19
08:37

Eyenovia announces expanded MicroProst Phase 3 program indication

Eyenovia confirmed a broad patient population for its Phase III MicroProst program for the lowering of intraocular pressure, or IOP. Following discussions with the FDA, the study population will include chronic angle closure glaucoma, as well as open angle glaucoma and ocular hypertension patients, representing a total addressable population of approximately 4M in the United States. As anticipated, the Phase III program will be optimized to consist of a single MicroProst Phase III trial and supplemented with existing data on latanoprost for IOP lowering.

EYEN Eyenovia
$5.10

-0.92 (-15.28%)

10/09/18
HCWC
10/09/18
INITIATION
Target $12
HCWC
Buy
Eyenovia initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Eyenovia with a Buy rating and $12 price target. The company's technology has the potential to change the existing method of administering topical ophthalmic drugs, the analyst tells investors in a research note.
10/09/18
10/09/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Outperform at Macquarie. 2. Tellurian (TELL) initiated with a Buy at BofA/Merrill. 3. NIO Inc. (NIO) initiated with a Neutral at JPMorgan and an Overweight at Morgan Stanley. 4. Eyenovia (EYEN) initiated with a Buy at H.C. Wainwright. 5. Garrett Motion (GTX) initiated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/30/19
HCWC
01/30/19
NO CHANGE
Target $14
HCWC
Buy
Eyenovia price target raised to $14 after MicroStat data at H.C. Wainwright
After Eyenovia announced results from the Phase 3 MIST-1 study of MicroStat, H.C. Wainwright analyst Raghuram Selvaraju said these are the first positive data in a Phase 3 setting, adding that he believes the data validate the Opteject delivery platform that is also utilized in MicroProst, MicroPine and MicroTears. He has increased his estimate of the probability of success for MicroStat to 75% from 65% and raised his price target on Eyenovia shares to $14 from $12 following the data readout. Selvaraju keeps a Buy rating on Eyenovia, which is up 17% to $3.08 in early afternoon trading.
01/30/19
LTCO
01/30/19
NO CHANGE
Target $35
LTCO
Buy
MIST-1 positive results provide further de-risking of Eyenovia's programs, says Ladenburg
Ladenburg analyst Matthew Kaplan notes that Eyenovia announced this morning that the MIST-1 Phase 3 study met its primary endpoint showing statistically significant superiority over the single-agent active control arms. The analyst believes the positive results from the MIST-1 study provide further de-risking of Eyenovia's programs by demonstrating strong efficacy of microdosing, and it is also an important validation of the platform delivery technology. This is particularly meaningful since all the programs use the same fundamental delivery microdose technology, he notes, adding that he looks forward to the readout of the topline Phase 3 results for the MIST-2 study in the near-term, and the presentation of the detailed results from the MIST-1 and MIST-2 trials at a medical conference later this year. Kaplan reiterates a Buy rating and a $35 price target on the shares.

TODAY'S FREE FLY STORIES

IQ

iQIYI

$22.76

0.17 (0.75%)

16:51
02/21/19
02/21
16:51
02/21/19
16:51
Earnings
iQIYI reports Q4 EPS (70c), consensus (71c) »

Reports Q4 revenue $1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 20

    Mar

ECOL

US Ecology

$65.48

-0.48 (-0.73%)

16:49
02/21/19
02/21
16:49
02/21/19
16:49
Earnings
US Ecology sees double digit adjusted EBITDA growth in 2019 »

The strong performance we…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

APC

Anadarko

$43.84

-1.32 (-2.92%)

16:49
02/21/19
02/21
16:49
02/21/19
16:49
Syndicate
Breaking Syndicate news story on Anadarko »

Anadarko files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

  • 22

    May

XOG

Extraction Oil & Gas

$3.81

-0.1 (-2.56%)

16:49
02/21/19
02/21
16:49
02/21/19
16:49
Syndicate
Breaking Syndicate news story on Extraction Oil & Gas »

Extraction Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ECOL

US Ecology

$65.48

-0.48 (-0.73%)

16:48
02/21/19
02/21
16:48
02/21/19
16:48
Earnings
Breaking Earnings news story on US Ecology »

US Ecology sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ECOL

US Ecology

$65.48

-0.48 (-0.73%)

16:47
02/21/19
02/21
16:47
02/21/19
16:47
Earnings
US Ecology reports Q4 EPS 62c, consensus 63c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Z

Zillow

$35.03

0.22 (0.63%)

, ZG

Zillow

$35.07

0.22 (0.63%)

16:47
02/21/19
02/21
16:47
02/21/19
16:47
Hot Stocks
Breaking Hot Stocks news story on Zillow, Zillow »

Zillow down over 3% after…

Z

Zillow

$35.03

0.22 (0.63%)

ZG

Zillow

$35.07

0.22 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 11

    Mar

  • 25

    Mar

WIFI

Boingo Wireless

$24.78

-1.23 (-4.73%)

, QCOM

Qualcomm

$52.35

-0.1 (-0.19%)

16:47
02/21/19
02/21
16:47
02/21/19
16:47
Hot Stocks
Boingo Wireless names Mike Finley as new CEO »

Boingo Wireless (WIFI)…

WIFI

Boingo Wireless

$24.78

-1.23 (-4.73%)

QCOM

Qualcomm

$52.35

-0.1 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

  • 07

    Mar

  • 12

    Mar

  • 19

    Mar

  • 20

    Mar

  • 28

    Mar

  • 29

    Mar

HK

Halcon Resources

$1.79

-0.07 (-3.76%)

16:46
02/21/19
02/21
16:46
02/21/19
16:46
Hot Stocks
Halcon announces departures of CEO Floyd Wilson, CFO Mark Mize »

Halcon Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PIN

Pinterest

$23.23

(0.00%)

16:46
02/21/19
02/21
16:46
02/21/19
16:46
Periodicals
Pinterest files confidentially for IPO, eyeing a late-June listing, WSJ says »

Pinterest has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLRC

Solar Capital

$21.27

0.34 (1.62%)

16:45
02/21/19
02/21
16:45
02/21/19
16:45
Earnings
Solar Capital reports Q4 EPS 44c, consensus 43c »

At December 31, 2018, net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

TRIL

Trillium Therapeutics

$1.28

0.08 (6.67%)

16:45
02/21/19
02/21
16:45
02/21/19
16:45
Syndicate
Trillium Therapeutics files to sell common share units, no amount given »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDP

Goodrich Petroleum

$13.53

0.03 (0.22%)

16:44
02/21/19
02/21
16:44
02/21/19
16:44
Hot Stocks
Goodrich Petroleum announces year-end proved reserves grew 12% »

Goodrich Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 05

    Mar

  • 05

    Mar

  • 17

    Mar

NYMT

New York Mortgage

$6.25

-0.03 (-0.48%)

16:44
02/21/19
02/21
16:44
02/21/19
16:44
Earnings
New York Mortgage reports Q4 EPS 11c, consensus 15c »

"We generated net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CHSP

Chesapeake Lodging

$29.41

0.01 (0.03%)

16:42
02/21/19
02/21
16:42
02/21/19
16:42
Earnings
Breaking Earnings news story on Chesapeake Lodging »

Chesapeake Lodging sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

FLXN

Flexion

$14.22

-0.22 (-1.52%)

16:42
02/21/19
02/21
16:42
02/21/19
16:42
Hot Stocks
Flexion announces new data showing protective effects of triamcinolone acetonide »

Flexion Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

KNSL

Kinsale Capital Group

$61.63

-0.43 (-0.69%)

16:42
02/21/19
02/21
16:42
02/21/19
16:42
Earnings
Kinsale Capital Group reports Q4 EPS 46c, consensus 41c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

  • 27

    Mar

CHSP

Chesapeake Lodging

$29.41

0.01 (0.03%)

16:41
02/21/19
02/21
16:41
02/21/19
16:41
Earnings
Breaking Earnings news story on Chesapeake Lodging »

Chesapeake Lodging sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CHSP

Chesapeake Lodging

$29.41

0.01 (0.03%)

16:41
02/21/19
02/21
16:41
02/21/19
16:41
Earnings
Chesapeake Lodging reports Q4 adjusted FFO 54c, consensus 51c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GMED

Globus Medical

$47.68

0.05 (0.10%)

16:40
02/21/19
02/21
16:40
02/21/19
16:40
Earnings
Globus Medical sees FY19 EPS $1.72, consensus $1.72 »

The company today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 06

    Mar

SEM

Select Medical

$15.49

-0.11 (-0.71%)

16:40
02/21/19
02/21
16:40
02/21/19
16:40
Hot Stocks
Select Medical extends $500M share repurchase program »

Select Medical did not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ULH

Universal Logistics

$23.66

(0.00%)

16:39
02/21/19
02/21
16:39
02/21/19
16:39
Earnings
Universal Logistics reports Q4 EPS 32c, consensus 41c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CASA

Casa Systems

$11.96

-0.02 (-0.17%)

16:39
02/21/19
02/21
16:39
02/21/19
16:39
Hot Stocks
Casa Systems to acquire NetComm Wireless »

NetComm Wireless Limited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 13

    Mar

BIIB

Biogen

$320.99

-14.02 (-4.18%)

16:39
02/21/19
02/21
16:39
02/21/19
16:39
Downgrade
Biogen rating change  »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 28

    May

GMED

Globus Medical

$47.68

0.05 (0.10%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Earnings
Globus Medical reports Q4 EPS 43c, consensus 39c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 06

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.